Coronavirus disease 2019, hypertension, and renin-angiotensin-aldosterone system inhibitors.

Rizk, John G; Sanchis-Gomar, Fabian; Henry, Brandon M; Lippi, Giuseppe; Lavie, Carl J

Rizk, John G; Sanchis-Gomar, Fabian; Henry, Brandon M; Lippi, Giuseppe; Lavie, Carl J.

Afiliación

Rizk JG; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.
Sanchis-Gomar F; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Henry BM; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA.

Curr Opin Cardiol ; 37(5): 419-423, 2022 09 01.

Article en En | MEDLINE | ID: mdl-35913369

Asunto(s)

Tratamiento Farmacológico de COVID-19; Hipertensión; Antagonistas de Receptores de Angiotensina/uso terapéutico; Animales; Humanos; Hipertensión/tratamiento farmacológico; Sistema Renina-Angiotensina; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hipertensión Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Curr Opin Cardiol Asunto de la revista: CARDIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google